semaglutide compound banned is compounded covered by insurance The FDA's Decision to Ban Compounds: What You Need to Know Semaglutide in California — From – Hims & Hers pulls copycat

Starting in July 2026, eligible Medicare beneficiaries will gain access to certain weight-loss medications for $50 a month through a temporary initiative called the Medicare GLP-1 Bridge program

Tirzepatide is FDA-approved (for diabetes and weight loss, depending on the brand) and works as a dual-agonist, targeting GLP-1 and GIP receptors to reduce appetite, improve insulin response, and support weight loss

The Skinny Shot Weight loss injections have been in the news a lot lately, and for many people, they are a great option

Clinical studies confirm that GHK-Cu does not cause irritation or allergic responses

We also offer additional peptide therapies for cognitive improvement such as FG Loop Peptide, Synapsin Peptide, and Pinealon Peptide